USD
$0.00
(0.00%
)At Close (As of Oct 24, 2025)
$10.29B
Market Cap
143.27
P/E Ratio
0.46
EPS
$80.37
52 Week High
$45.87
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $790M |
| Total Revenue | $1.2B |
| Cost Of Revenue | $429M |
| Costof Goods And Services Sold | $429M |
| Operating Income | $102M |
| Selling General And Administrative | $415M |
| Research And Development | $99M |
| Operating Expenses | $688M |
| Investment Income Net | - |
| Net Interest Income | -$4.6M |
| Interest Income | $3.9M |
| Interest Expense | $8.5M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $110M |
| Income Before Tax | $98M |
| Income Tax Expense | $25M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $73M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $107M |
| Ebitda | $217M |
| Net Income | $73M |
| Field | Value (USD) |
|---|---|
| Total Assets | $2.6B |
| Total Current Assets | $608M |
| Cash And Cash Equivalents At Carrying Value | $162M |
| Cash And Short Term Investments | $162M |
| Inventory | $189M |
| Current Net Receivables | $207M |
| Total Non Current Assets | $1.9B |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $366M |
| Intangible Assets Excluding Goodwill | $366M |
| Goodwill | $981M |
| Investments | - |
| Long Term Investments | $251M |
| Short Term Investments | $0 |
| Other Current Assets | $50M |
| Other Non Current Assets | - |
| Total Liabilities | $639M |
| Total Current Liabilities | $176M |
| Current Accounts Payable | $25M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $28M |
| Total Non Current Liabilities | $463M |
| Capital Lease Obligations | $98M |
| Long Term Debt | $346M |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $444M |
| Other Current Liabilities | $79M |
| Other Non Current Liabilities | $27M |
| Total Shareholder Equity | $1.9B |
| Treasury Stock | - |
| Retained Earnings | $1.1B |
| Common Stock | $1.6M |
| Common Stock Shares Outstanding | $160M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | $288M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $110M |
| Capital Expenditures | $31M |
| Change In Receivables | - |
| Change In Inventory | -$18M |
| Profit Loss | - |
| Cashflow From Investment | -$35M |
| Cashflow From Financing | -$254M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | $50M |
| Dividend Payout Common Stock | $50M |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | -$276M |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | $73M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $790M |
| Total Revenue | $1.2B |
| Cost Of Revenue | $429M |
| Costof Goods And Services Sold | $429M |
| Operating Income | $102M |
| Selling General And Administrative | $415M |
| Research And Development | $99M |
| Operating Expenses | $688M |
| Investment Income Net | - |
| Net Interest Income | -$4.6M |
| Interest Income | $3.9M |
| Interest Expense | $8.5M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $110M |
| Income Before Tax | $98M |
| Income Tax Expense | $25M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $73M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $107M |
| Ebitda | $217M |
| Net Income | $73M |
| Field | Value |
|---|---|
| Ex Dividend Date | 2025-08-18 |
| Declaration Date | 2025-08-06 |
| Record Date | 2025-08-18 |
| Payment Date | 2025-08-29 |
| Amount | 0.08 |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Bio-Techne Corporation (Ticker: TECH) is a premier global provider of high-quality life science reagents, instruments, and services, with a strong focus on clinical diagnostics and research applications. Based in Minneapolis, Minnesota, the company utilizes cutting-edge technologies to drive innovation across key areas such as genomics, proteomics, and cellular analysis. Bio-Techne supports a wide range of clients, including academic institutions, pharmaceutical companies, and clinical laboratories, thereby positioning itself as a pivotal contributor to advancements in scientific research and diagnostic solutions on a global scale.